Baxter International Inc (NYSE:BAX) Institutional Investor Sentiment Analysis

Baxter International Inc. (NYSE:BAX) Logo

Sentiment for Baxter International Inc (NYSE:BAX)

Baxter International Inc (NYSE:BAX) institutional sentiment decreased to 0.89 in 2019 Q2. Its down -0.07, from 0.96 in 2019Q1. The ratio worsened, as 300 institutional investors increased and opened new equity positions, while 338 cut down and sold their holdings in Baxter International Inc. The institutional investors in our partner’s database now own: 413.22 million shares, down from 417.48 million shares in 2019Q1. Also, the number of institutional investors holding Baxter International Inc in their top 10 equity positions was flat from 8 to 8 for the same number . Sold All: 34 Reduced: 304 Increased: 222 New Position: 78.

Baxter International Inc. provides a portfolio of renal and hospital products. The company has market cap of $44.38 billion. The firm operates through two divisions, Hospital Products and Renal. It has a 29.09 P/E ratio. The Hospital Products segment makes intravenous solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products.

The stock decreased 1.01% or $0.89 during the last trading session, reaching $86.93. About 1.58M shares traded. Baxter International Inc. (NYSE:BAX) has risen 17.67% since September 13, 2018 and is uptrending. It has outperformed by 17.67% the S&P500.

Analysts await Baxter International Inc. (NYSE:BAX) to report earnings on October, 30. They expect $0.84 EPS, up 5.00 % or $0.04 from last year’s $0.8 per share. BAX’s profit will be $428.87 million for 25.87 P/E if the $0.84 EPS becomes a reality. After $0.89 actual EPS reported by Baxter International Inc. for the previous quarter, Wall Street now forecasts -5.62 % negative EPS growth.

Third Point Llc holds 22.06% of its portfolio in Baxter International Inc. for 23.00 million shares. Sector Gamma As owns 462,305 shares or 6.09% of their US portfolio. Moreover, Veritas Asset Management Llp has 5.51% invested in the company for 7.89 million shares. The Colorado-based Obermeyer Wood Investment Counsel Lllp has invested 3.17% in the stock. Spf Beheer Bv, a Netherlands-based fund reported 1.04 million shares.

Baxter International Inc. (NYSE:BAX) Ratings Coverage

Ratings analysis reveals 75% of Baxter International’s analysts are positive. Out of 4 Wall Street analysts rating Baxter International, 3 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $75 while the high is $9500. The stock’s average target of $87.75 is 0.94% above today’s ($86.93) share price. BAX was included in 10 notes of analysts from April 3, 2019. The stock has “Equal-Weight” rating by Barclays Capital on Monday, April 15. As per Friday, July 26, the company rating was maintained by Credit Suisse. The stock of Baxter International Inc. (NYSE:BAX) has “Buy” rating given on Thursday, June 20 by Piper Jaffray. Wells Fargo maintained it with “Outperform” rating and $89 target in Wednesday, April 3 report. The firm has “Outperform” rating by Wells Fargo given on Wednesday, June 26.

More notable recent Baxter International Inc. (NYSE:BAX) news were published by: Finance.Yahoo.com which released: “Baxter International (NYSE:BAX) Seems To Use Debt Rather Sparingly – Yahoo Finance” on August 05, 2019, also Seekingalpha.com with their article: “Stocks To Watch: Apple, IPOs And German Auto – Seeking Alpha” published on September 07, 2019, Finance.Yahoo.com published: “Could Baxter International Inc.’s (NYSE:BAX) Investor Composition Influence The Stock Price? – Yahoo Finance” on September 10, 2019. More interesting news about Baxter International Inc. (NYSE:BAX) were released by: Seekingalpha.com and their article: “Baxter to acquire Cheetah Medical for up to $230M – Seeking Alpha” published on September 10, 2019 as well as Seekingalpha.com‘s news article titled: “Baxter to commercialize metabolic monitoring device – Seeking Alpha” with publication date: August 15, 2019.

Baxter International Inc. (NYSE:BAX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.